Thomas DELALE,Stephane MILANO,Thierry ABRIBAT,David CLEMMONS
申请号：
US16420656
公开号：
US20190359676A1
申请日:
2019.05.23
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present technology generally relates to compounds, in particular peptides comprising the heparin-binding domain (HBD) of insulin-like growth factor binding protein-2 (IGFBP-2) for the modulation of metabolic disorders. The present technology also generally relates to uses of such compounds in methods for preventing and/or treating metabolic disorders and in compositions and formulations for such uses.
